Cite
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.
MLA
Yuan, Shu-Qiang, et al. “Author Correction: Perioperative Toripalimab and Chemotherapy in Locally Advanced Gastric or Gastro-Esophageal Junction Cancer: A Randomized Phase 2 Trial.” Nature Medicine, vol. 30, no. 2, Feb. 2024, p. 605. EBSCOhost, https://doi.org/10.1038/s41591-024-02800-6.
APA
Yuan, S.-Q., Nie, R.-C., Jin, Y., Liang, C.-C., Li, Y.-F., Jian, R., Sun, X.-W., Chen, Y.-B., Guan, W.-L., Wang, Z.-X., Qiu, H.-B., Wang, W., Chen, S., Zhang, D.-S., Ling, Y.-H., Xi, S.-Y., Cai, M.-Y., Huang, C.-Y., Yang, Q.-X., … Wang, F. (2024). Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature Medicine, 30(2), 605. https://doi.org/10.1038/s41591-024-02800-6
Chicago
Yuan, Shu-Qiang, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, et al. 2024. “Author Correction: Perioperative Toripalimab and Chemotherapy in Locally Advanced Gastric or Gastro-Esophageal Junction Cancer: A Randomized Phase 2 Trial.” Nature Medicine 30 (2): 605. doi:10.1038/s41591-024-02800-6.